Search results
AstraZeneca prepares fresh COVID push to regulators after antibody's phase 3 success
FierceBiotech· 14 hours agoResults from the phase 3 SUPERNOVA study show that the company’s investigational long-acting ...
Long Covid: the cause, the consequence, the future of clinical trials
Clinical Trials Arena via Yahoo Finance· 17 hours agoImperial College London hopes its recently published Long Covid study will lead to further clinical...
Long Dismissed, Chronic Lyme Is Finally in the Spotlight
Time via AOL· 7 hours agoIn addition, Akiko Iwasaki, an immunobiologist at the Yale University School of ...real,” Aucott...
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 20 hours agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...
Chronic Lyme Disease: Why COVID May Spark Better Tests and Treatment
Well and Good· 2 days agoPeople with chronic Lyme disease (or PTLDS) are understudied and have limited treatment options, but...
Trying to solve the ‘cruel mystery,’ lupus - MinnPost
MinnPost· 10 hours agoWhile pregnant with her second child, Shamiere Schwahn noticed something was off. The symptoms she...
Sanofi to make €1bn biomanufacturing investment in France
Pharmaceutical Technology via Yahoo Finance· 3 days agoSanofi plans to invest €1bn in Vitry-sur-Seine to construct a new unit in a bid to double the...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 2 days agoDuring the March quarter, the U....Paxlovid still beat sales forecasts. Notably, revenue from the...
Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA
Digital Journal· 3 days ago...terms or at all and other matters that could affect the availability or commercial potential of Aptevo's product candidates, business or economic disruptions due to catastrophes or other events, including natural disasters or public health crises such as the coronavirus (referred to as COVID-19),...
Earnings call: Invivyd optimistic about PEMGARDA's market potential
Investing.com· 4 days agoInvivyd is committed to expanding its product offerings and is working on securing reimbursement and...